Synteract Inks Buy of Harrison Clinical

Synteract, which is backed by Gryphon Investors, has agreed to buy Harrison Clinical Research. Financial terms were not announced. Munich, Germany-based Harrison is a clinical research company.

PE HUB Community

Join the 12523 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget